Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry
about
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CYAllogeneic hematopoietic cell transplantation for myelodysplastic syndrome: the past decade.Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.
P2860
Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry
description
article
@en
im November 2003 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2003
@uk
name
Peripheral blood is safer than ...... ults from the Spanish registry
@en
Peripheral blood is safer than ...... ults from the Spanish registry
@nl
type
label
Peripheral blood is safer than ...... ults from the Spanish registry
@en
Peripheral blood is safer than ...... ults from the Spanish registry
@nl
prefLabel
Peripheral blood is safer than ...... ults from the Spanish registry
@en
Peripheral blood is safer than ...... ults from the Spanish registry
@nl
P2093
P2860
P356
P1476
Peripheral blood is safer than ...... ults from the Spanish registry
@en
P2093
C Martínez
Grupo Español de Trasplante Hematopoyético
M C del Cañizo
M V Mateos
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704246
P407
P577
2003-11-01T00:00:00Z